Prostate cancer is the most common malignancy among men of all races and one of the leading causes of cancer death in this population (Schroder, 2010).
Although significant advances have been made in the early screening and treatment of prostate cancer by various pharmacological, surgical and radiotherapy approaches during the past decade, the traditional radical treatment approach may often lead to severe adverse consequences and decreased life quality. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.
Written by:
Pacher P. Are you the author?
Section on Oxidative Stress Tissue Injury, Laboratory of Physiological Studies, National Institutes of Health, NIAAA, Bethesda, Maryland, USA.
Reference: Br J Pharmacol. 2012 Jul 31. Epub ahead of print.
doi: 10.1111/j.1476-5381.2012.02121.x
PubMed Abstract
PMID: 22849856
UroToday.com Prostate Cancer Section
